UMichael Levin, uVannevar Bush USolwazi weBiology e-Tufts University kanye noDavid Kaplan, uStern Family Professor of Engineering e-Tufts bangabasunguli be-Morphoceuticals Inc., bakhonjiswe kanye nethimba labo: ukukhula kabusha, ukubhalwa kabusha kwezicubu ezimakiwe, kanye nokubuyiselwa kokusebenza kwe-X. i-laevis hindlimb ilandela ukuchayeka kafushane, amahora angama-24 kunoveli yezidakamizwa eziningi, ukwelashwa okuvuselelayo okulethwa i-bioreactor egqokekayo. Izicubu ezivuselelwe ezakhiwe isikhumba esisha, ithambo, imithambo yegazi, nezinzwa zedlule kakhulu inkimbinkimbi namandla enzwa wezilawuli zocwaningo.
U-Levin wathi “Izinto eziphilayo ezifana no-X. laevis, amandla azo okuvuselela alinganiselwe ebudala abonisa ezinye zemikhawulo eyinhloko yabantu, amamodeli abalulekile okuhlola ukungenelela nokuthola izibangeli ezingabuyisela kokubili isimo nokusebenza”. U-Kaplan wengeze ngokuthi “Le datha ikhombisa ikhono lethu 'lokuqalisa' ngempumelelo izindlela ezivuselelayo ezilwaneni ezinomgogodla; nokho-ke, ukuhunyushwa kwalokhu okutholakele ezilwaneni ezincelisayo kusazoboniswa njengesinyathelo esilandelayo esibalulekile kule nqubo”.
UGreg Bailey, MD, i-CEO kwaJuvenescence Ltd., umxhasi wokuqala we-Morphocueticals, waphawula “uDkt. U-Levin no-Kaplan baphayona izindlela ezintsha zokuvumela ukuvuselelwa kwezitho, izicubu nezitho ezisebenzayo. Lokhu okutholakele kumemezela ukusetshenziswa kokuqala kwesethi entsha yamathuluzi amasha azothuthukiswa i-Morphoceuticals futhi azosivumela ukuthi sihlole izindlela ezintsha zokwelapha ezivuselelayo ngezindlela ezihluke ngempela”. Ubuye wengeza ngokuthi "Izicelo ezingase zibe khona kuhloswe ngazo ukuthi ngelinye ilanga zisize iziguli zinqobe umthwalo wokulahlekelwa izitho nemilenze ngendlela imithi yendabuko engeke yakwazi, yingakho uJuvenescence etshale imali futhi eqhubeka nokweseka inkundla yesayensi yeMorphoceuticals."
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- These findings herald the first application of a new of new set of tools that will be further developed by Morphoceuticals and will allow us to explore new approaches to regenerative treatment in ways that are truly unique”.
- He added that “The potential applications are aimed at one day helping patients overcome the burden of loss of organs and limbs in ways that traditional medicine cannot,and that was why Juvenescence invested and continues to be so supportive of Morphoceuticals’.
- laevis, whose limited regenerative capacities in adulthood mirror some of the key limitations of humans, are important models with which to test interventions and discover triggers that could restore both form and function”.
